| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7988998 | PURDUE PHARMA | Sustained-release tramadol formulations with 24-hour efficacy |
Oct, 2023
(a month from now) | |
Ryzolt is owned by Purdue Pharma.
Ryzolt contains Tramadol Hydrochloride.
Ryzolt has a total of 1 drug patent out of which 0 drug patents have expired.
Ryzolt was authorised for market use on 30 December, 2008.
Ryzolt is available in tablet, extended release;oral dosage forms.
The generics of Ryzolt are possible to be released after 27 October, 2023.
Drugs and Companies using TRAMADOL HYDROCHLORIDE ingredient
Market Authorisation Date: 30 December, 2008
Treatment: NA
Dosage: TABLET, EXTENDED RELEASE;ORAL
How can I launch a generic of RYZOLT before it's drug patent expiration?
More Information on Dosage
RYZOLT family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic